Here, we are going to share Caplin Point Laboratories Share Price Target 2025, 2026, 2027, 2028, 2030, 2035, 2040 on the basis of its fundamental and technical analysis.
Caplin Point Laboratories Ltd is a pharmaceutical company that specializes in the creation, production, and marketing of pharmaceutical formulations.
It has a strong presence in emerging markets, particularly in Latin America, and has expanded its focus to regulated markets like the U.S., Canada, and Australia.
Caplin Point Laboratories Share Key Information
| Company Name | Caplin Point Laboratories Ltd. |
| Headquarters | Chennai, India |
| Sectors | Pharmaceuticals & Drugs |
| Market Cap | ₹ 16,730.17 Cr. |
| No. of Shares | 7.60 Cr. |
| Book Value | ₹ 201.93 |
| Dividend Yield | 0.23% |
| ROCE | 28.92% |
| ROE | 22.69% |
| Face Value | ₹ 2 |
| Sales Growth | 18.25% |
| Profit Growth | 21.11% |
Caplin Point Laboratories Business Sector
Caplin Point Laboratories Ltd operates in the pharmaceutical sector, focusing on the production and distribution of formulations and specialty injectables.
The company serves emerging countries such as Latin America, Africa, and Southeast Asia while also moving into regulated areas such as the United States and Europe.
Board Members
- C C Paarthipan – Chairman (Non-Executive)
- D. Sathyanarayanan – Independent Director
- C K Gariyali – Independent Director
- Deenadayalan Singaram – Independent Director
- R Nagendran – Independent Director
Caplin Point Laboratories Share Quarterly Results
| PARTICULARS | Jun 2024 | Sep 2024 |
|---|---|---|
| Net Sales | 185.64 | 207.93 |
| Total Expenditure | 104.26 | 109.77 |
| Operating Profit | 81.38 | 98.16 |
| Other Income | 21.50 | 43.01 |
| Interest | 0.02 | 0.02 |
| Depreciation | 6.18 | 6.49 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 96.68 | 134.66 |
| Tax | 24.14 | 28.92 |
| Profit After Tax | 72.54 | 105.74 |
| Adjusted EPS (Rs) | 9.54 | 13.91 |
Caplin Point Laboratories Company Profits and Losses
| PARTICULARS | Mar 2023 | Mar 2024 |
|---|---|---|
| Net Sales | 528.61 | 625.09 |
| Total Expenditure | 309.23 | 338.01 |
| Operating Profit | 219.38 | 287.08 |
| Other Income | 99.54 | 105.84 |
| Interest | 0.12 | 0.10 |
| Depreciation | 25.65 | 27.08 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 293.15 | 365.74 |
| Tax | 58.89 | 82.03 |
| Net Profit | 234.26 | 283.71 |
| Adjusted EPS (Rs.) | 30.86 | 37.35 |
Caplin Point Laboratories Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹2000 | ₹2242 |
| 2026 | ₹2251 | ₹2493 |
| 2027 | ₹2501 | ₹2743 |
| 2028 | ₹2754 | ₹2992 |
| 2029 | ₹3005 | ₹3296 |
| 2030 | ₹3321 | ₹3485 |
| 2035 | ₹5124 | ₹5546 |
| 2040 | ₹7246 | ₹7634 |
Caplin Point Laboratories Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹2000 |
| February 2025 | ₹2014 |
| March 2025 | ₹2012 |
| April 2025 | ₹2037 |
| May 2025 | ₹2067 |
| June 2025 | ₹2099 |
| July 2025 | ₹2164 |
| August 2025 | ₹2203 |
| September 2025 | ₹2228 |
| October 2025 | ₹2206 |
| November 2025 | ₹2222 |
| December 2025 | ₹2242 |
Based on the 2025 forecast, the initial target of Caplin Point Laboratories share can could be ₹2000 and by the end of the year, the share price target is estimated to reach ₹2242.
Caplin Point Laboratories Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹2251 |
| February 2026 | ₹2265 |
| March 2026 | ₹2264 |
| April 2026 | ₹2289 |
| May 2026 | ₹2317 |
| June 2026 | ₹2350 |
| July 2026 | ₹2413 |
| August 2026 | ₹2462 |
| September 2026 | ₹2479 |
| October 2026 | ₹2457 |
| November 2026 | ₹2473 |
| December 2026 | ₹2493 |
Based on the 2026 forecast, the initial target of Caplin Point Laboratories share can could be ₹2251 and by the end of the year, the share price target is estimated to reach ₹2493.
Caplin Point Laboratories Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹2501 |
| February 2027 | ₹2513 |
| March 2027 | ₹2515 |
| April 2027 | ₹2540 |
| May 2027 | ₹2570 |
| June 2027 | ₹2600 |
| July 2027 | ₹2661 |
| August 2027 | ₹2713 |
| September 2027 | ₹2719 |
| October 2027 | ₹2709 |
| November 2027 | ₹2724 |
| December 2027 | ₹2743 |
Based on the 2027 forecast, the initial target of Caplin Point Laboratories share can could be ₹2501 and by the end of the year, the share price target is estimated to reach ₹2743.
Caplin Point Laboratories Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹2754 |
| February 2028 | ₹2767 |
| March 2028 | ₹2766 |
| April 2028 | ₹2791 |
| May 2028 | ₹2821 |
| June 2028 | ₹2852 |
| July 2028 | ₹2919 |
| August 2028 | ₹2965 |
| September 2028 | ₹2981 |
| October 2028 | ₹2950 |
| November 2028 | ₹2975 |
| December 2028 | ₹2992 |
Based on the 2028 forecast, the initial target of Caplin Point Laboratories share can could be ₹2754 and by the end of the year, the share price target is estimated to reach ₹2992.
Caplin Point Laboratories Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹3005 |
| February 2029 | ₹3019 |
| March 2029 | ₹3017 |
| April 2029 | ₹3042 |
| May 2029 | ₹3101 |
| June 2029 | ₹3070 |
| July 2029 | ₹3213 |
| August 2029 | ₹3233 |
| September 2029 | ₹3126 |
| October 2029 | ₹3253 |
| November 2029 | ₹3286 |
| December 2029 | ₹3296 |
Based on the 2029 forecast, the initial target of Caplin Point Laboratories share can could be ₹3005 and by the end of the year, the share price target is estimated to reach ₹3296.
Caplin Point Laboratories Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹3321 |
| February 2030 | ₹3352 |
| March 2030 | ₹3365 |
| April 2030 | ₹3386 |
| May 2030 | ₹3396 |
| June 2030 | ₹3381 |
| July 2030 | ₹3412 |
| August 2030 | ₹3426 |
| September 2030 | ₹3435 |
| October 2030 | ₹3456 |
| November 2030 | ₹3465 |
| December 2030 | ₹3485 |
Based on the 2030 forecast, the initial target of Caplin Point Laboratories share can could be ₹3321 and by the end of the year, the share price target is estimated to reach ₹3485.
Caplin Point Laboratories Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹5124 |
| April 2035 | ₹5241 |
| July 2035 | ₹5326 |
| October 2035 | ₹5425 |
| December 2035 | ₹5546 |
Based on the 2035 forecast, the initial target of Caplin Point Laboratories share can could be ₹5124 and by the end of the year, the share price target is estimated to reach ₹5546.
Caplin Point Laboratories Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹7246 |
| April 2040 | ₹7325 |
| July 2040 | ₹7456 |
| October 2040 | ₹7519 |
| December 2040 | ₹7634 |
Based on the 2040 forecast, the initial target of Caplin Point Laboratories share can could be ₹7246 and by the end of the year, the share price target is estimated to reach ₹7634.
Caplin Point Laboratories Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 70.56% |
| FIIs | 3.69% |
| DIIs | 1.84% |
| Others | 0% |
| Public | 23.91% |
Caplin Point Laboratories Company Competitors
- Concord Biotech
- Alembic Pharma
- Neuland Laboratories
- Jubilant Pharmova
- ErisLifesciences
- Indegene
- Strides Pharma Science
Bull Case of Caplin Point Laboratories (Reasons to Invest)
- Strong growth potential in regulated markets like the U.S., supported by FDA approvals for niche injectable products.
- Expanding product portfolio and investments in R&D and infrastructure.
- The company has grown its profits by 22.00% during the last three years.
Bear Case of Caplin Point Laboratories (Risks Involved)
- Heavy dependence on Latin America exposes the company to geopolitical and currency risks.
- For the past three years, the company’s sales growth has been disappointing at 9.00 percent.
Caplin Point Laboratories Share Price Target: FAQ
What will be the target of Caplin Point Laboratories Share for the year 2025?
By the end of the year 2025, its share price can reach ₹2242.
What will be the target of Caplin Point Laboratories Share for the year 2026?
By the end of the year 2026, its share price can reach ₹2493.
What will be the target of Caplin Point Laboratories Share for the year 2027?
By the end of the year 2027, its share price can reach ₹2743.
What will be the target of Caplin Point Laboratories Share for the year 2028?
By the end of the year 2028, its share price can reach ₹2992.
What will be the target of Caplin Point Laboratories Share for the year 2029?
By the end of the year 2029, its share price can reach ₹3296.
What will be the target of Caplin Point Laboratories Share for the year 2030?
By the end of the year 2030 its share price can reach ₹3485.
What is the Current market cap of Caplin Point Laboratories company?
At present the market cap of this company is ₹ 16,730.17 Cr.
What is the NSE symbol of Caplin Point Laboratories company?
The symbol of this company in NSE exchange is CAPLIPOINT.
What is the BSE symbol of Caplin Point Laboratories company?
The symbol of this company in BSE exchange is 524742.
